ArticleEMBO molecular medicine2023
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance.
Li-Min Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled itcites it